Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

173.79USD
--
Change (% chg)

-- (--)
Prev Close
$173.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
112
52-wk High
$195.20
52-wk Low
$147.84

LZAGF.PK

Chart for LZAGF.PK

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.20
Market Cap(Mil.): CHF9,700.26
Shares Outstanding(Mil.): 52.92
Dividend: 2.50
Yield (%): 1.36

Financials

  LZAGF.PK Industry Sector
P/E (TTM): 26.78 45.12 30.76
EPS (TTM): 6.85 -- --
ROI: 7.45 -1.32 14.89
ROE: 17.20 -0.98 16.30

Lonza to buy U.S. drug capsule maker Capsugel from KKR for $5.5 billion

Swiss pharmaceutical supplier Lonza Group AG on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP for $5.5 billion in cash to broaden its product range.

Dec 15 2016

Exclusive: Lonza says in talks to buy Capsugel; deal could top $5 billion - sources

Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.

Dec 12 2016

BRIEF-Lonza Group expects to reach 2018 guidance year early

* Says strong momentum in q3 gives us confidence to specify that core ebit is on track to cross 15% growth line for full-year 2016

Oct 27 2016

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

Oct 04 2016

Lonza buys InterHealth in health push

ZURICH Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Aug 15 2016

Lonza buys InterHealth in health push

* Lonza to spend up to $300 million on health-supplements target

Aug 15 2016

Earnings vs. Estimates